Cite
Circulating miR-320a-3p and miR-483-5p level associated with pharmacokinetic–pharmacodynamic profiles of rivaroxaban.
MLA
Zhang, Hanxu, et al. “Circulating MiR-320a-3p and MiR-483-5p Level Associated with Pharmacokinetic–pharmacodynamic Profiles of Rivaroxaban.” Human Genomics, vol. 16, no. 1, Dec. 2022, pp. 1–15. EBSCOhost, https://doi.org/10.1186/s40246-022-00445-5.
APA
Zhang, H., Zhang, Z., Liu, Z., Mu, G., Xie, Q., Zhou, S., Wang, Z., Cao, Y., Tan, Y., Wei, X., Yuan, D., Xiang, Q., & Cui, Y. (2022). Circulating miR-320a-3p and miR-483-5p level associated with pharmacokinetic–pharmacodynamic profiles of rivaroxaban. Human Genomics, 16(1), 1–15. https://doi.org/10.1186/s40246-022-00445-5
Chicago
Zhang, Hanxu, Zhuo Zhang, Zhiyan Liu, Guangyan Mu, Qiufen Xie, Shuang Zhou, Zhe Wang, et al. 2022. “Circulating MiR-320a-3p and MiR-483-5p Level Associated with Pharmacokinetic–pharmacodynamic Profiles of Rivaroxaban.” Human Genomics 16 (1): 1–15. doi:10.1186/s40246-022-00445-5.